Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Pancreatic Neoplasms × olaparib × Clear all

Phase

Status

Sponsor Class

OTHER 8 INDUSTRY 6 NIH 2 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Thymoma 1 Sarcoma 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neuroendocrine Tumors 1 Neoplasm Metastasis 1 Mesothelioma 1 Lung Neoplasms 1 Fallopian Tube Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Gemcitabine 3 Pancreaticoduodenectomy 2 Erlotinib Hydrochloride 2 olaparib 1 ferric carboxymaltose 1 binimetinib 1 Taxes 1 Surveys and Questionnaires 1 Radiosurgery 1 Radiofrequency Ablation 1 Radiation 1 Propranolol 1 Positron Emission Tomography Computed Tomography 1 Oxaliplatin 1 Nivolumab 1 Ipilimumab 1 Immobilization 1 Etodolac 1 Endoscopic Ultrasound-Guided Fine Needle Aspiration 1 Drainage 1 Curcumin 1 Congresses as Topic 1 Celecoxib 1 Capecitabine 1 Analgesia, Patient-Controlled 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02511223 2023-04-19

10

Sheba Medical Center

Phase 2 Completed

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡